Literature DB >> 12115819

Effects of mechanical processing on phase composition.

Harry G Brittain1.   

Abstract

One factor that must be considered during drug development process is that various types of pharmaceutical manufacturing can alter the physical characteristics of the drug entity. These effects become particularly important during scale-up of processing operations, because new and unanticipated results can become manifest in systems of insufficient characterization. Any transformed drug substance or altered dosage form could exhibit an altered solubility or dissolution rate that might produce an undesirable bioavailability profile. Some of the more interesting mechanical manipulations that have the potential to yield problems include particle size reduction and compression, and such investigations are the focus of this minireview. Copyright 2002 Wiley-Liss Inc.

Mesh:

Substances:

Year:  2002        PMID: 12115819     DOI: 10.1002/jps.10115

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Identifying and mapping surface amorphous domains.

Authors:  Stuart Ward; Mark Perkins; Jianxin Zhang; Clive J Roberts; Claire E Madden; Shen Y Luk; Nikin Patel; Stephen J Ebbens
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

2.  A new twist in the old story-can compression induce mixing of phase separated solid dispersions? A case study of spray-dried miconazole-PVP VA64 solid dispersions.

Authors:  Abhishek Singh; Jan Van Humbeeck; Guy Van den Mooter
Journal:  Pharm Res       Date:  2014-05-22       Impact factor: 4.200

3.  Metal-Assisted and Microwave-Accelerated Evaporative Crystallization.

Authors:  Melissa A Pinard; Kadir Aslan
Journal:  Cryst Growth Des       Date:  2010-11-03       Impact factor: 4.076

4.  Investigation of solid phase composition on tablet surfaces by grazing incidence X-ray diffraction.

Authors:  Vishal Koradia; Mikko Tenho; Heidi Lopez de Diego; Michiel Ringkjøbing-Elema; Jørn Møller-Sonnergaard; Jarno Salonen; Vesa-Pekka Lehto; Jukka Rantanen
Journal:  Pharm Res       Date:  2011-07-09       Impact factor: 4.200

5.  Molecular interaction among probucol/PVP/SDS multicomponent system investigated by solid-state NMR.

Authors:  Adchara Pongpeerapat; Kenjirou Higashi; Yuichi Tozuka; Kunikazu Moribe; Keiji Yamamoto
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

6.  Devitrification of amorphous celecoxib.

Authors:  Piyush Gupta; Arvind K Bansal
Journal:  AAPS PharmSciTech       Date:  2005-09-30       Impact factor: 3.246

7.  Amorphous solid dispersions of sulfonamide/Soluplus® and sulfonamide/PVP prepared by ball milling.

Authors:  Vincent Caron; Yun Hu; Lidia Tajber; Andrea Erxleben; Owen I Corrigan; Patrick McArdle; Anne Marie Healy
Journal:  AAPS PharmSciTech       Date:  2013-02-07       Impact factor: 3.246

8.  Spray-Dried Amorphous Solid Dispersions of Atorvastatin Calcium for Improved Supersaturation and Oral Bioavailability.

Authors:  Jaewook Kwon; Bhupendra Raj Giri; Eon Soo Song; Jinju Bae; Junseong Lee; Dong Wuk Kim
Journal:  Pharmaceutics       Date:  2019-09-06       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.